PDMR dealing

 21st Mar 2017

EKF Diagnostics Holdings plc (AIM: EKF) announces that on 21 March 2017, the Company was notified that Harwood Capital LLP ("Harwood") acquired 8,000,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") as investment manager to North Atlantic Smaller Companies Investment Trust PLC ("NAIT"). Christopher Mills, the Company's Non-Executive Chairman, is a partner and Chief Investment Officer of Harwood and a director and shareholder in NAIT.

Following the above transaction, which was completed on 20 March 2017 at a price of 19.5p pence per share, NAIT's interest is now in 98,000,000 Ordinary Shares, representing 21.12% of the Company's issued share capital. The interests of Oryx International Growth Fund Limited ("Oryx", whose investment adviser is Harwood) remains as previously disclosed in 40,000,000 Ordinary Shares, representing 8.62% of the Company's issued share capital. Mr Mills is also a director and shareholder in Oryx.

The total indirect beneficial interest of Mr Mills is, following the above transaction, therefore now in 138,000,000 Ordinary Shares, representing 29.73% of the Company's issued share capital.

EKF Diagnostics Holdings plc
Julian Baines, CEO
Richard Evans, Finance Director and COO
00 44 29 2071 0570
 
N+1 Singer
Alex Price / Alex Laughton-Scott
00 44 20 7496 3000

Walbrook PR Limited
Paul McManus
Lianne Cawthorne

00 44 20 7933 8780 or ekf@walbrookpr.com
00 44 7980 541 893
00 44 7584 391 303

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Harwood Capital LLP, as investment manager to North Atlantic Smaller Companies Investment Trust PLC ("NAIT")

2

Reason for the notification

a)

Position/status

Christopher Mills, the Company's Non-Executive Chairman, is a partner and Chief Investment Officer of Harwood Capital LLP and a director and shareholder in NAIT

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

EKF Diagnostics Holdings plc

b)

LEI

213800DXTF3EAUK1AR05

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrumentIdentification code

Ordinary shares of 1p each (“Ordinary Shares”) ISIN Code: GB0031509804

b)

Nature of the transaction

Acquisition of shares

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

19.5p

8,000,000

 

d)

Aggregated information
- Aggregated volume
- Price

n/a

e)

Date of the transaction

20 March 2017

f)

Place of the transaction

London Stock Exchange